Chartwell Investment Partners’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,908	Closed	-$643K	–	424
2019 Q4	$643K	Buy	8,908 +4,045	+83%	+$498K	0.02%	377
2019 Q3	$682K	Sell	4,863 -78	-2%	-$13K	0.02%	377
2019 Q2	$905K	Sell	4,941 -16,934	-77%	-$2.89M	0.03%	384
2019 Q1	$3.48M	Buy	21,875 +384	+2%	+$55.6K	0.11%	252
2018 Q4	$2.06M	Sell	21,491 -11,951	-36%	-$1.37M	0.07%	329
2018 Q3	$4.72M	Buy	33,442 +8,504	+34%	+$1.31M	0.14%	220
2018 Q2	$3.9M	Sell	24,938 -3,495	-12%	-$549K	0.12%	239
2018 Q1	$4.58M	Sell	28,433 -370	-1%	-$62.8K	0.16%	201
2017 Q4	$4.74M	Buy	28,803 +6,839	+31%	+$663K	0.16%	206
2017 Q3	$1.37M	Sell	21,964 -19,482	-47%	-$1.53M	0.05%	359
2017 Q2	$3.3M	Buy	41,446 +14,575	+54%	+$1.05M	0.12%	225
2017 Q1	$1.91M	Sell	26,871 -34,271	-56%	-$2.01M	0.07%	294
2016 Q4	$3.12M	Buy	+61,142	New	+$2.88M	0.11%	269